Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis
Open Access
- 15 January 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 111 (2) , 816-828
- https://doi.org/10.1182/blood-2007-05-090472
Abstract
Several RNA binding proteins (RBPs) have been implicated in the progression of chronic myelogenous leukemia (CML) from the indolent chronic phase to the aggressKeywords
This publication has 71 references indexed in Scilit:
- FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemiaJournal of Clinical Investigation, 2007
- High levels of the BCR/ABL oncoprotein are required for the MAPK-hnRNP-E2–dependent suppression of C/EBPα-driven myeloid differentiationBlood, 2007
- From mRNA Metabolism to Cancer Therapy: Chronic Myelogenous Leukemia Shows the WayClinical Cancer Research, 2007
- RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extractsNature Protocols, 2006
- The La Protein-RNA Complex SurfacesMolecular Cell, 2006
- Impaired DNA Replication within Progenitor Cell Pools Promotes LeukemogenesisPLoS Biology, 2005
- Distinct Protein Phosphatase 2A Heterotrimers Modulate Growth Factor Signaling to Extracellular Signal-regulated Kinases and AktJournal of Biological Chemistry, 2005
- Mechanisms of Transformation by MLLCritical Reviews™ in Eukaryotic Gene Expression, 2004
- Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignanciesJournal of Cellular Physiology, 2000
- The p120-v-Abl Protein Interacts with E2F-1 and Regulates E2F-1 Transcriptional ActivityPublished by Elsevier ,1997